Literature DB >> 7589045

The characteristics of the inhibition of serum cholinesterase by metoclopramide.

S G Graham1, A W Crossley.   

Abstract

The inhibition of serum cholinesterase by metoclopramide has been previously characterised in vitro at high dilution of the enzyme. We examined the effect of varying enzyme dilution over a range of 1000 fold dilution, and assay temperature at 25 degrees C and 37 degrees C on the fractional inhibition of enzyme activity by metoclopramide. Neither enzyme concentration nor reaction temperature affected this fractional inhibition. Concentrations of metoclopramide producing 50% inhibition of enzyme activity were in the range 1.0-1.9 x 10(-6) M. Lineweaver-Burk analysis of the enzyme reaction suggests that the pattern of this inhibition is competitive.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7589045     DOI: 10.1007/BF00198302

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  A method for the detection of atypical forms of human serum cholinesterase; determination of dibucaine numbers.

Authors:  W KALOW; K GENEST
Journal:  Can J Biochem Physiol       Date:  1957-06

2.  The inhibitory effect of metoclopramide on plasma cholinesterase activity.

Authors:  J R Kambam; W C Parris; J J Franks; B V Sastry; R Naukam; B E Smith
Journal:  Can J Anaesth       Date:  1988-09       Impact factor: 5.063

3.  The effect of procainamide on plasma cholinesterase activity.

Authors:  J R Kambam; R J Naukam; B V Sastry
Journal:  Can J Anaesth       Date:  1987-11       Impact factor: 5.063

4.  Benzamides and cholinesterases.

Authors:  C Vacca; S Maione; A Tozzi; E Marmo
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1987-02

5.  Dose-dependent effect of metoclopramide on cholinesterases and suxamethonium metabolism.

Authors:  Y J Kao; J Tellez; D R Turner
Journal:  Br J Anaesth       Date:  1990-08       Impact factor: 9.166

6.  The pharmacokinetics of metoclopramide in man with observations in the dog.

Authors:  D N Bateman; C Kahn; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

7.  Correlation of succinylcholine duration of action with plasma cholinesterase activity in subjects with the genotypically normal enzyme.

Authors:  J Viby-Mogensen
Journal:  Anesthesiology       Date:  1980-12       Impact factor: 7.892

8.  Serum cholinesterase, pregnancy and suxamethonium.

Authors:  J A Wildsmith
Journal:  Anaesthesia       Date:  1972-01       Impact factor: 6.955

9.  Is serum cholinesterase activity a predictor of succinyl choline sensitivity? An assessment of four methods.

Authors:  R T Evans; J Wroe
Journal:  Clin Chem       Date:  1978-10       Impact factor: 8.327

10.  Examination of the correlation of serum metoclopramide levels with antiemetic efficacy in patients receiving cisplatin.

Authors:  S M Grunberg; J E McDermed; L Bernstein; J L Cohen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

View more
  1 in total

1.  Metoclopramide does not prolong duration of action of landiolol attenuating the hemodynamic response to induction of anesthesia and tracheal intubation.

Authors:  Satoki Inoue; Ryuichi Abe; Masahiko Kawaguchi; Hiroshi Kobayashi; Hitoshi Furuya
Journal:  J Anesth       Date:  2010-05-08       Impact factor: 2.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.